Recurrent transcriptional responses in AML and MDS patients treated with decitabine. Upadhyay P, Beales J, Shah NM, Gruszczynska A, et al. Exp Hematol 2022;111:50-65.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Upadhyay P, Beales J, Shah NM, Gruszczynska A, et al. Recurrent transcriptional responses in AML and MDS patients treated with decitabine. Exp Hematol 2022;111:50-65.
PMID: 35429619